- US 10-year Treasury yields recover from nine-week low, stock futures print mild gains.
- Fears of incapacity to tame South African covid variant, inflation fears and Fed rate hike underpin US Treasury yields.
- Equities lick their wounds amid China’s cautious optimism ahead of key US data.
Having witnessed a show of risk aversion the previous day, market players remain divided during early Wednesday amid a lack of major catalysts.
Mixed concerns over the current vaccines’ ability to tackle the Omicron crisis and Fed Chair Jerome Powell’s hawkish comments were the latest help to the US Treasury yields. However, the stock futures consolidate recent losses as China stays hopeful of a better 2021 and Aussie GDP also offered a positive surprise, not to forget stimulus hopes from the US and Japan.
That said, US 10-year Treasury yields rise five basis points (bps) to 1.492% whereas the S&P 500 Futures print 0.56% intraday gains at the latest.
Moderna’s Chief Stéphane Bancel said, per the Financial Times (FT), “that existing vaccines will be much less effective at tackling Omicron than earlier strains of Covid-19 and warned it would take months before pharmaceutical companies can manufacture new variant-specific jabs at scale.” The comments from the pharmaceutical leader were contrasted by the representatives of Pfizer and Oxford marking an absence of evidence supporting the fears.
In his testimony on the CARES act before the Senate Banking Committee, Fed’s Powell said, “It is time to retire the term ‘transitory’ for inflation." The Fed boss also suggested the risk of more persistent inflation and signaled favor for discussing faster taper in the December meeting.
Elsewhere, the US CB Consumer Confidence dropped to a nine-month low and housing numbers also came in softer while Australia Q3 GDP came in better-than-forecast. Additionally, China’s Vice Premier Liu He expects strong 2021 GDP for the dragon nation whereas tensions between Russia and Ukraine escalate.
Having witnessed hawkish comments from Fed’s Powell, versus the looming covid crisis, market players will pay close attention to the incoming US data, especially relating to activity and employment, for fresh impulse. Hence, November’s ADP Employment Change and ISM Manufacturing PMI will be crucial for fresh impulse, as well as the second round of Fed Chair Powell’s testimony.
Should Powell keep his bullish bias, irrespective of the virus woes, the yields have further north to go while the stocks may witness losses.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.